These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 17679833)
1. Involvement of the pancreatic renin-angiotensin system in insulin resistance and the metabolic syndrome. Leung PS; de Gasparo M J Cardiometab Syndr; 2006; 1(3):197-203. PubMed ID: 17679833 [TBL] [Abstract][Full Text] [Related]
2. Mechanisms of protective effects induced by blockade of the renin-angiotensin system: novel role of the pancreatic islet angiotensin-generating system in Type 2 diabetes. Leung PS Diabet Med; 2007 Feb; 24(2):110-6. PubMed ID: 17257271 [TBL] [Abstract][Full Text] [Related]
3. The renin-angiotensin system: a target of and contributor to dyslipidemias, altered glucose homeostasis, and hypertension of the metabolic syndrome. Putnam K; Shoemaker R; Yiannikouris F; Cassis LA Am J Physiol Heart Circ Physiol; 2012 Mar; 302(6):H1219-30. PubMed ID: 22227126 [TBL] [Abstract][Full Text] [Related]
4. Of the renin-angiotensin system and reactive oxygen species Type 2 diabetes and angiotensin II inhibition. Leiter LA; Lewanczuk RZ Am J Hypertens; 2005 Jan; 18(1):121-8. PubMed ID: 15691626 [TBL] [Abstract][Full Text] [Related]
5. [Prevention of type 2 diabetes mellitus due to antihypertensive treatment affecting renin-angiotensin system]. Boucek P Vnitr Lek; 2006 Sep; 52(9):791-6. PubMed ID: 17091602 [TBL] [Abstract][Full Text] [Related]
6. Why blockade of the renin-angiotensin system reduces the incidence of new-onset diabetes. Jandeleit-Dahm KA; Tikellis C; Reid CM; Johnston CI; Cooper ME J Hypertens; 2005 Mar; 23(3):463-73. PubMed ID: 15716683 [TBL] [Abstract][Full Text] [Related]
7. [Renin-angiotensin system and insulin resistance: carbohydrate-metabolism disorders]. Shimamoto K Nihon Naika Gakkai Zasshi; 2006 Sep; 95(9):1769-73. PubMed ID: 17037313 [No Abstract] [Full Text] [Related]
8. Pancreatic islet renin angiotensin system: its novel roles in islet function and in diabetes mellitus. Leung PS; Carlsson PO Pancreas; 2005 May; 30(4):293-8. PubMed ID: 15841036 [TBL] [Abstract][Full Text] [Related]
9. Prevention of type 2 diabetes mellitus through inhibition of the Renin-Angiotensin system. Scheen AJ Drugs; 2004; 64(22):2537-65. PubMed ID: 15516153 [TBL] [Abstract][Full Text] [Related]
10. Renin-angiotensin-aldosterone system and oxidative stress in cardiovascular insulin resistance. Cooper SA; Whaley-Connell A; Habibi J; Wei Y; Lastra G; Manrique C; Stas S; Sowers JR Am J Physiol Heart Circ Physiol; 2007 Oct; 293(4):H2009-23. PubMed ID: 17586614 [TBL] [Abstract][Full Text] [Related]
12. Telmisartan is a promising cardiometabolic sartan due to its unique PPAR-gamma-inducing property. Yamagishi S; Takeuchi M Med Hypotheses; 2005; 64(3):476-8. PubMed ID: 15617852 [TBL] [Abstract][Full Text] [Related]
13. The renin-angiotensin system as a target to solve the riddle of endocrine pancreas homeostasis. Graus-Nunes F; Souza-Mello V Biomed Pharmacother; 2019 Jan; 109():639-645. PubMed ID: 30404071 [TBL] [Abstract][Full Text] [Related]
14. Preventing diabetes in patients with hypertension: one more reason to block the renin-angiotensin system. Cooper ME; Tikellis C; Thomas MC J Hypertens Suppl; 2006 Mar; 24(1):S57-63. PubMed ID: 16601575 [TBL] [Abstract][Full Text] [Related]
15. Renin-angiotensin system inhibitor and statins combination therapeutics - what have we learnt? Koh KK; Sakuma I; Hayashi T; Kim SH; Chung WJ Expert Opin Pharmacother; 2015 May; 16(7):949-53. PubMed ID: 25747324 [TBL] [Abstract][Full Text] [Related]
16. The role of the renin-angiotensin system in the development of insulin resistance in skeletal muscle. Henriksen EJ; Prasannarong M Mol Cell Endocrinol; 2013 Sep; 378(1-2):15-22. PubMed ID: 22564510 [TBL] [Abstract][Full Text] [Related]
17. The role of renin-angiotensin system blockade in the management of hypertension associated with the cardiometabolic syndrome. Sharma AM; Engeli S J Cardiometab Syndr; 2006; 1(1):29-35. PubMed ID: 17675902 [TBL] [Abstract][Full Text] [Related]
18. The role of renin-angiotensin agents in altering the natural history of type 2 diabetes mellitus. Lardizabal JA; Deedwania PC Curr Cardiol Rep; 2010 Nov; 12(6):464-71. PubMed ID: 20809236 [TBL] [Abstract][Full Text] [Related]
19. Renin-angiotensin system inhibition prevents type 2 diabetes mellitus. Part 2. Overview of physiological and biochemical mechanisms. Scheen AJ Diabetes Metab; 2004 Dec; 30(6):498-505. PubMed ID: 15671919 [TBL] [Abstract][Full Text] [Related]
20. Anti-diabetic effect of blockade of the renin-angiotensin system. Ando K; Fujita T Diabetes Obes Metab; 2006 Jul; 8(4):396-403. PubMed ID: 16776746 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]